Exome Asset Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,700	Closed	-$2.62M	–	63
2024 Q1	$2.62M	Buy	+14,700	New	+$2.62M	2.24%	16